Dr. Sorror is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
- University of Assiut Faculty of MedicineClass of 1993
Certifications & Licensure
- MT State Medical License 2022 - 2026
- WA State Medical License 2005 - 2024
Clinical Trials
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2004 Dec 01
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Start of enrollment: 2010 Mar 18
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsLate effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for inter...David Buchbinder, Diane J. Nugent, Ruta Brazauskas, Zhiwei Wang, Mahmoud Aljurf
Biology of Blood and Marrow Transplantation. 2012-12-01 - 206 citationsLate Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T CellsAna Cordeiro, Evandro D. Bezerra, Alexandre V. Hirayama, Joshua A. Hill, Qian Wu
Biology of Blood and Marrow Transplantation. 2020-01-01 - 21 citationsEvaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leuke...Ryan D. Cassaday, D. Alan Potts, Philip A. Stevenson, Merav Bar, George E. Georges
Leukemia & Lymphoma. 2016-03-22
Journal Articles
- Pre-Transplant Expressions of microRNAs, Comorbidities, and Post-Transplant MortalityMohamed L Sorror, Muneesh Tewari, Nature
Press Mentions
- Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
- Age No Longer a Barrier to Stem Cell Transplantation for Older PatientsNovember 2nd, 2011
- Use of Low-Toxicity Conditioning Regimen Prior to Cell Transplantation Appears Promising for Older Adults with Blood, Bone Marrow CancersNovember 1st, 2011
Grant Support
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2011–2012
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2007–2008
Hospital Affiliations
- Fred Hutchinson Cancer CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: